Daratumumab, bortezomib, lenalidomide and dexamethasone, upfront autologous transplant and lenalidomide maintenance for newly diagnosed multiple myeloma
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Oren Pasvolsky, Muhammad Bilal Abid, Denai Milton, Mark Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Guilin Tang, Asad Haider, Yosra Aljawai, Partow Kebriaei, Mahmoud Gaballa, Krina Patel, Jing Christine Ye, Sheeba Thomas, Robert Orlowski, Richard Champlin, Elizabeth Shpall, Muzaffar Qazilbash
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108476157
Cites:
Cited by:
Related to: